Study to determine which stool test is best for colorectal cancer detection

by Texas Tech UniversityNavkiran Shokar, M.D., M.P.H., M.A., of Texas Tech University Health Sciences Center El Paso (TTUHSC El Paso) is part of a study to assess the accuracy of fecal immunochem

Updated on: June 28,2024 7

Study to determine which stool test is best for colorectal cancer detection

by Texas Tech UniversityNavkiran Shokar, M.D., M.P.H., M.A., of Texas Tech University Health Sciences Center El Paso (TTUHSC El Paso) is part of a study to assess the accuracy of fecal immunochem

Updated on:June 28,2024 7

Targeting cancer's hidden master regulators

by Columbia University Irving Medical CenterSchematic of the VIPER (A), OncoTarget (B), and OncoTreat (C) methodologies. G.E.S.: gene expression signature. MoR: mode of regulation—i.e., genes who

Updated on: April 14,2024 15

Targeting cancer's hidden master regulators

by Columbia University Irving Medical CenterSchematic of the VIPER (A), OncoTarget (B), and OncoTreat (C) methodologies. G.E.S.: gene expression signature. MoR: mode of regulation—i.e., genes who

Updated on:April 14,2024 15

New framework for using AI in health care considers medical knowledge, practices, procedures, values

by Carnegie Mellon UniversityCredit: Pixabay/CC0 Public DomainHealth care organizations are looking to artificial intelligence (AI) tools to improve patient care, but their translation into clini

Updated on: April 22,2024 20

New framework for using AI in health care considers medical knowledge, practices, procedures, values

by Carnegie Mellon UniversityCredit: Pixabay/CC0 Public DomainHealth care organizations are looking to artificial intelligence (AI) tools to improve patient care, but their translation into clini

Updated on:April 22,2024 20

Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

by International Association for the Study of Lung CancerLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA clinical trial testing the toxicity of a KRAS inhibitor demons

Updated on: March 14,2024 20

Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

by International Association for the Study of Lung CancerLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA clinical trial testing the toxicity of a KRAS inhibitor demons

Updated on:March 14,2024 20

Treatment advances and predictive biomarkers stand to improve bladder cancer care

byUniversity of North Carolina Health CareCredit: AI-generated imageRecent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk

Updated on: November 30,2024 0

Treatment advances and predictive biomarkers stand to improve bladder cancer care

byUniversity of North Carolina Health CareCredit: AI-generated imageRecent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk

Updated on:November 30,2024 0

Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal

by ECOG-ACRIN Cancer Research GroupCredit: CC0 Public DomainResults from a clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) show a striking improvement for patients who received che

Updated on: September 28,2024 0

Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal

by ECOG-ACRIN Cancer Research GroupCredit: CC0 Public DomainResults from a clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) show a striking improvement for patients who received che

Updated on:September 28,2024 0

Novel selenium carrier protein regulates ferroptosis in tumors and the brain

byTohoku UniversityPRDX6 is a critical regulator of ferroptosis surveillance. As a selenium- acceptor protein, PRDX6 aids in intracellular selenium utilization for efficient selenoprotein biosyn

Updated on: December 01,2024 0

Novel selenium carrier protein regulates ferroptosis in tumors and the brain

byTohoku UniversityPRDX6 is a critical regulator of ferroptosis surveillance. As a selenium- acceptor protein, PRDX6 aids in intracellular selenium utilization for efficient selenoprotein biosyn

Updated on:December 01,2024 0

Incidence of early-stage breast CA, CRC up with ACA adoption

(HealthDay)—After adoption of the Affordable Care Act (ACA), there was an increase in the incidence of early-stage breast and colorectal cancer, according to a research letter published online Nov. 2

Updated on: April 20,2024 12

Incidence of early-stage breast CA, CRC up with ACA adoption

(HealthDay)—After adoption of the Affordable Care Act (ACA), there was an increase in the incidence of early-stage breast and colorectal cancer, according to a research letter published online Nov. 2

Updated on:April 20,2024 12

Inflammatory-nutritional score helps predict survival in new multiple myeloma

by Elana GotkineFor patients with newly diagnosed multiple myeloma (NDMM), a nomogram based on the inflammatory-nutritional score (INS) may help to predict survival, according to a study published onl

Updated on: January 16,2024 14

Inflammatory-nutritional score helps predict survival in new multiple myeloma

by Elana GotkineFor patients with newly diagnosed multiple myeloma (NDMM), a nomogram based on the inflammatory-nutritional score (INS) may help to predict survival, according to a study published onl

Updated on:January 16,2024 14

Breast cancer survivors can safely interrupt therapy during pregnancy: study

by Amy NortonFor young women who survive breast cancer, a new study offers some reassurance about pregnancy: Pausing hormonal therapy to have a baby does not raise the risk of a cancer recurrence, at

Updated on: February 18,2024 14

Breast cancer survivors can safely interrupt therapy during pregnancy: study

by Amy NortonFor young women who survive breast cancer, a new study offers some reassurance about pregnancy: Pausing hormonal therapy to have a baby does not raise the risk of a cancer recurrence, at

Updated on:February 18,2024 14

Automated bone scan index prognostic for prostate cancer

(HealthDay)—The automated Bone Scan Index (aBSI) is an independent prognostic imaging biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC), according to a stud

Updated on: April 01,2024 13

Automated bone scan index prognostic for prostate cancer

(HealthDay)—The automated Bone Scan Index (aBSI) is an independent prognostic imaging biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC), according to a stud

Updated on:April 01,2024 13

Clinical trial: Less extensive breast cancer surgery results in fewer swollen arms

by Karolinska InstitutetCredit:New England Journal of Medicine(2024). DOI: 10.1056/NEJMoa2313487It is possible to leave most of the lymph nodes in the armpit, even if one or two of th

Updated on: April 06,2024 0

Clinical trial: Less extensive breast cancer surgery results in fewer swollen arms

by Karolinska InstitutetCredit:New England Journal of Medicine(2024). DOI: 10.1056/NEJMoa2313487It is possible to leave most of the lymph nodes in the armpit, even if one or two of th

Updated on:April 06,2024 0